FSSNX
Price
$29.19
Change
-$0.40 (-1.35%)
Updated
Nov 14 closing price
WMCVX
Price
$12.40
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSSNX vs WMCVX

Header iconFSSNX vs WMCVX Comparison
Open Charts FSSNX vs WMCVXBanner chart's image
Fidelity Small Cap Index
Price$29.19
Change-$0.40 (-1.35%)
VolumeN/A
CapitalizationN/A
Wasatch Small Cap Value
Price$12.40
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSSNX vs WMCVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. WMCVX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and WMCVX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. WMCVX (1.78B). FSSNX pays higher dividends than WMCVX: FSSNX (1.36) vs WMCVX (0.00). FSSNX was incepted earlier than WMCVX: FSSNX (13 years) vs WMCVX (27 years). WMCVX is a more actively managed with annual turnover of: 61.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than WMCVX: FSSNX (0) vs WMCVX (2000). FSSNX (33.68) and WMCVX (33.33) have marching annual gain over last year. WMCVX return over 5 years is better than : 58.22 vs. FSSNX (51.61).
FSSNXWMCVXFSSNX / WMCVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years27 years-
Gain YTD18.33021.09487%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B1.78B1,509%
Annual Yield % from dividends1.360.00-
Returns for 1 year33.6833.33101%
Returns for 3 years0.324.777%
Returns for 5 years51.6158.2289%
Returns for 10 years93.17107.3087%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TR32.290.15
+0.47%
Tootsie Roll Industries
AU24.12-0.51
-2.07%
AngloGold Ashanti plc
CDNA22.78-0.54
-2.32%
CareDx
ATNF2.89-0.09
-3.02%
180 Life Sciences Corp
ANIX3.07-0.18
-5.54%
Anixa Biosciences